AR and acute myeloid leukemia: We investigated whether AR is expressed in AML using immunohistochemistry (IHC) on BM trephines from 140 consecutive AML patients (MRC cytogenetic risk: 14 favorable, 94 intermediate, 14 adverse, 18 no record) and compared to 58 age-matched controls.